Prescribed opioids in Ohio decline for seventh consecutive year

Prescribed opioids in Ohio decline for seventh consecutive year

For the seventh consecutive year, the number of opioid prescriptions in Ohio declined in 2019, according to a State of Ohio Board of Pharmacy’s Ohio Automated Rx Reporting System (OARRS) report.

The total doses of opioids dropped 48 percent from 793 million in 2012 to 415 million in 2019, according to OARRS data. From 2012 to 2019, the number of prescriptions issued to Ohioans dropped by 5 million.

“Ohio has cut the number of opioids in circulation by nearly half from its peak in 2012,” Steven W. Schierholt, State of Ohio Board of Pharmacy executive director, said. “Ohio’s commitment to working with our prescriber community to encourage safe opioid prescribing is clearly having an impact that will hopefully prevent individuals from misusing these medications in the first place.”

OARRS was founded in 2006. It collects information on all outpatient prescriptions for controlled substances dispensed by Ohio-licensed pharmacies and personally furnished by Ohio prescribers. It also collects information on two noncontrolled substances, gabapentin, and naltrexone.

The data is made available to prescribers when they treat patients, pharmacists when filling prescriptions, and law enforcement officers and regulatory agencies during active investigations.

More than 240 million patient reports were requested by prescribers and pharmacists last year.